€
9. 15
+0.15
+1.6667%
€
2.36B Market Cap
- P/E Ratio
- Div Yield
6 Volume
0 Eps
€ 9
Previous Close Want to track 64Z and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Keymed Biosciences Inc. (64Z) Statistics
Valuation metrics
Market Cap 2.36B
Enterprise value 94.26M
Trailing P/E (ttm) -3.32
Forward P/E -
PEG ratio -
Price/Sales (ttm) 2.61
Price/Book (mrq) 5.3
Enterprise Value/Revenue 1.03
Enterprise Value/EBITDA -1.34
Overview
Shares outstanding 294.6M
Float 219.45M
Shares short -
% Held by insiders 0.25%
% Held by institutions 0.3%
Average volume (10 days) 27
Average volume (90 days) 59
Price summary
52-Week low 4.94
52-Week high 9.55
Beta -0.15
50-Day moving average 7.42
200-Day moving average 6.72
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -0.73%
Operating margin -2.28%
Operational effectiveness
Return on assets -0.1%
Return on equity -0.2%
Income Statement
Revenue (ttm) 91.72M
Revenue per share (ttm) 2.61
Quarterly revenue growth (yoy) -0.42%
Gross profit (ttm) 80.29M
EBITDA -70.33M
Net income to common (ttm) -66.92M
Diluted EPS (ttm) -0.24
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 246.32M
Total cash per share (mrq) 6.53
Total debt (mrq) 100.96M
Total Debt/Equity (mrq) 28.42
Current ratio (mrq) 2.9%
Book value per share (mrq) 1.2
Cash Flow
Cash flow statement -91.22M
Levered free cash flow (LFCF) -96.02M
